Skip to content

study to check the effect of yoga and yava kalpana in management of prediabetes.

A randomized clinical trial to evaluate the combined effect of yavas kalpana and yoga therapy in management of prediabetes. - nil

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/08/072641
Enrollment
90
Registered
2024-08-19
Start date
Unknown
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E70-E88- Metabolic disorders

Interventions

None listed

Sponsors

Institute for Ayurved Studies And Research,Shri Krishna Ayush University, Kurkshetra
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patient sign consent form. 2. BMI greater than 23 kilogram per metersquare. 3. Impaired fasting glucose from 100 miligram per decilitre to 126 miligram per decilitre. 4.Hba1c range 5.7 to 6.4 percent.

Exclusion criteria

Exclusion criteria: 1.Age below 35 and above 55 years. 2. Patients with history of any chronic disorder or any health challenging diseases. 3. Patients having Impaired fasting glucose less than 100mg/dl and greater than 126mg/dl. 4. Patients having Hba1c Range more than 6.4% and less than 5.7% 5. Patients having hypertension, neuromuscular disease,disc prolapse,osteoarthritisand any type of hernia. 6. Drugs known to influence glycemic status like steroids,antipschychotic,birth control pills,HIV medicines

Design outcomes

Primary

MeasureTime frame
To prevent the patient from landing into type 2 diabetes mellitus.Timepoint: 0,15,30 days and post treatment follow up

Secondary

MeasureTime frame
To control Hba1c levelTimepoint: Pre and post treatment

Countries

India

Contacts

Public ContactManisha

Institue for ayurved studies and research,faculty of ayurved kurukshetra.

sheokandmanisha0510@gmail.com9468144601

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026